MSCs significantly alleviated CCl4-mediated liver fibrosis by decreasing the proportion of Th17 cells and increasing the levels of CD4+IL-10+ T cells and immunosuppressive factors (including kynurenine, IDO, and IL-10). The gene discussed is IL10; the disease is Hepatic fibrosis.